Antifibrotic and Anti-Inflammatory Activity of a Neuroleptic Drug on the Model of Pulmonary Fibrosis

被引:0
作者
A. M. Dygai
E. G. Skurikhin
T. V. Andreeva
O. V. Pershina
L. A. Ermolaeva
E. S. Khmelevskaya
V. A. Krupin
A. M. Reztsova
I. E. Stepanova
机构
[1] Siberian Division of the Russian Academy of Medical Sciences,Institute of Pharmacology
来源
Bulletin of Experimental Biology and Medicine | 2012年 / 152卷
关键词
bleomycin; pulmonary fibrosis; neuroleptic drug; stem cells; committed hemopoietic and mesenchymal precursors;
D O I
暂无
中图分类号
学科分类号
摘要
The effect of course treatment with neuroleptic haloperidol on the inflammatory response and state of the connective tissue in the lungs of C57Bl/6 mice was studied on the model of toxic pulmonary fibrosis induced by intratracheal administration of bleomycin. This neuroleptic decreased the inflammatory response and reduced the growth of the connective tissue in the lungs. The anti-infl ammatory effect of haloperidol is related to a decrease in activity of bone marrow hemopoietic stem cells and committed hemopoietic precursors. The antifibrotic effect of this drug is associated with inhibition of mesenchymal precursor cells.
引用
收藏
页码:679 / 683
页数:4
相关论文
共 50 条
[21]   Caffeic acid ethanolamide induces antifibrosis, anti-inflammatory, and antioxidant effects protects against bleomycin-induced pulmonary fibrosis [J].
Huang, Cheng -Wei ;
Lee, Shih-Yi ;
Du, Chen-Xuan ;
Wu, Shao-Tung ;
Kuo, Yueh-Hsiung ;
Ku, Hui- Chun .
BIOMEDICINE & PHARMACOTHERAPY, 2024, 173
[22]   Transplantation of adipose-derived mesenchymal stem cells attenuates pulmonary fibrosis of silicosis via anti-inflammatory and anti-apoptosis effects in rats [J].
Chen, Shangya ;
Cui, Guanqun ;
Peng, Cheng ;
Lavin, Martin F. ;
Sun, Xiaoying ;
Zhang, Enguo ;
Yang, Ye ;
Guan, Yingjun ;
Du, Zhongjun ;
Shao, Hua .
STEM CELL RESEARCH & THERAPY, 2018, 9
[23]   Transplantation of adipose-derived mesenchymal stem cells attenuates pulmonary fibrosis of silicosis via anti-inflammatory and anti-apoptosis effects in rats [J].
Shangya Chen ;
Guanqun Cui ;
Cheng Peng ;
Martin F. Lavin ;
Xiaoying Sun ;
Enguo Zhang ;
Ye Yang ;
Yingjun Guan ;
Zhongjun Du ;
Hua Shao .
Stem Cell Research & Therapy, 9
[24]   A drug-responsive multicellular human spheroid model to recapitulate drug-induced pulmonary fibrosis [J].
Saygili, Ecem ;
Devamoglu, Utku ;
Goker-Bagca, Bakiye ;
Goksel, Ozlem ;
Biray-Avci, Cigir ;
Goksel, Tuncay ;
Yesil-Celiktas, Ozlem .
BIOMEDICAL MATERIALS, 2022, 17 (04)
[25]   Radiation induced pulmonary fibrosis as a model of progressive fibrosis: Contributions of DNA damage, inflammatory response and cellular senescence genes [J].
Beach, Tyler A. ;
Johnston, Carl J. ;
Groves, Angela M. ;
Williams, Jacqueline P. ;
Finkelstein, Jacob N. .
EXPERIMENTAL LUNG RESEARCH, 2017, 43 (03) :134-149
[26]   3D pulmonary fibrosis model for anti-fibrotic drug discovery by inkjet-bioprinting [J].
Kang, Dayoon ;
Lee, Yunji ;
Kim, Wookyeom ;
Lee, Hwa-Rim ;
Jung, Sungjune .
BIOMEDICAL MATERIALS, 2023, 18 (01)
[27]   Engineered self-regulating macrophages for targeted anti-inflammatory drug delivery [J].
Klimak, Molly ;
Cimino, Amanda ;
Lenz, Kristin L. ;
Springer, Luke E. ;
Collins, Kelsey H. ;
Harasymowicz, Natalia S. ;
Xu, Nathan ;
Pham, Christine T. N. ;
Guilak, Farshid .
ARTHRITIS RESEARCH & THERAPY, 2024, 26 (01)
[28]   DR7dA, a Novel Antioxidant Peptide Analog, Demonstrates Antifibrotic Activity in Pulmonary Fibrosis In Vivo and In Vitro [J].
Cheng, Lu ;
Wang, Dan ;
Deng, Bochuan ;
Li, Jieru ;
Zhang, Jiao ;
Guo, Xiaomin ;
Yan, Tiantian ;
Yue, Xin ;
An, Yingying ;
Zhang, Bangzhi ;
Xie, Junqiu .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2022, 382 (02) :100-112
[29]   Anti-inflammatory drug resistance selects putative cancer stem cells in a cellular model for genetically predisposed colon cancer [J].
Telang, Nitin .
ONCOLOGY LETTERS, 2018, 15 (01) :642-648
[30]   An endostatin-derived peptide orally exerts anti-fibrotic activity in a murine pulmonary fibrosis model [J].
Nishimoto, Tetsuya ;
Mlakar, Logan ;
Takihara, Takahisa ;
Feghali-Bostwick, Carol .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2015, 28 (02) :1102-1105